Pozen MT 100 Benefit In Migraine Does Not Outweigh Tardive Dyskinesia Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Peripheral & Central Nervous System Drugs Advisory Committee says additional studies of the naproxen/metoclopramide product must show an effect on two-hour pain-free response.